National Committee on Vital and Health Statistics: Meeting, 16025 [2019-07709]

Download as PDF Federal Register / Vol. 84, No. 74 / Wednesday, April 17, 2019 / Notices and will also be publicly available on the Duke-Margolis website at https:// healthpolicy.duke.edu/events/analysisdata-standards-workshop. Dated: April 12, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019–07700 Filed 4–16–19; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES amozie on DSK9F9SC42PROD with NOTICES National Committee on Vital and Health Statistics: Meeting Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee hearing. Name: National Committee on Vital and Health Statistics (NCVHS), Full Committee Meeting. Date and Times: Wednesday, June 5, 2019: 9:00 a.m.–5:00 p.m. (EST), Thursday, June 6, 2019: 8:30 a.m.–3:00 p.m. (EST) Place: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW, Rm. 505A, Washington, DC 20201. Status: Open. Purpose: At the June 5–6, 2019 meeting, the Committee will deliberate draft recommendations for the HHS Secretary, move forward on activities outlined in the NCVHS 2019 workplan, and hold discussions on several health data policy topics. Anticipated action items during this meeting include a letter that outlines recommendations to the Secretary and an accompanying report focused on a framework for health information privacy and security. Specifically, the Privacy, Confidentiality and Security Subcommittee will provide an update to the full Committee regarding its working meeting held in March 2019 focused on health information privacy and security beyond the scope of HIPAA. This will include discussion of a draft report that will lay out a framework for extending basic protections for health information privacy and security, a result of two years of NCVHS hearings and deliberations, to understand the environment and consider what might be a workable framework that supports innovative use of health information to advance health and wellness and reduces administrative burden, while protecting the rights of information subjects. Together with this draft report, the Subcommittee plans to present a draft set of recommendations to the HHS Secretary based on the framework VerDate Sep<11>2014 18:23 Apr 16, 2019 Jkt 247001 put forth in the report for full Committee deliberation. The Subcommittee on Standards will review the timeline of its ICD–11 evaluation project and discuss any refinements that result from exploration of existing research on the impact of the transition to ICD–10, ICD–10–CM, and ICD–10–PCS. The Subcommittee will update the full Committee regarding progress on plans for an August expert roundtable meeting, which will focus on identifying research questions HHS could address to evaluate benefit and cost of the upcoming transition from ICD–10 to ICD–11 for mortality and morbidity. The Subcommittee will report on continued progress on the elements of a Predictability Roadmap in follow up to its December 2018 hearing—the current focus will be on evaluating the function and purpose of the Designated Standards Maintenance Organizations (DSMOs) in light of changes in the health care standards environment and the need for harmonization of administrative and clinical standards. Finally, the Subcommittee anticipates continuing discussion and possible activities in collaboration with the Office of the National Coordinator for Health Information and Technology (ONC) regarding the opportunity for burden reduction through convergence of administrative and clinical data standards using the prior authorization transaction as a use-case. The Subcommittee on Population Health will provide an update on its work to address community data needs, including use-cases, for the full Committee to consider providing as input to the Federal Data Strategy. The Committee will further refine the remainder of its 2019 workplan and discuss potential options moving into fiscal year 2020. The times and topics are subject to change. Please refer to the posted agenda for any updates. Contact Persons For More Information: Substantive program information may be obtained from Rebecca Hines, MHS, Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782, telephone (301) 458–4715. Summaries of meetings and a roster of Committee members are available on the home page of the NCVHS website: www.ncvhs.hhs.gov, where further information including an agenda and instructions to access the broadcast of the meeting will also be posted. Should you require reasonable accommodation, please contact the CDC PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 16025 Office of Equal Employment Opportunity on (770) 488–3210 as soon as possible. Dated: April 11, 2019. Sharon Arnold, Associate Deputy Assistant Secretary for Planning and Evaluation, Science and Data Policy, Office of the Assistant Secretary for Planning and Evaluation. [FR Doc. 2019–07709 Filed 4–16–19; 8:45 am] BILLING CODE 4151–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Clinical Trial Planning and Implementation Grant (R34 and U01). Date: May 23, 2019. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Reed Solomon Shabman, Ph.D., Scientific Review Officer, Scientific Review Program DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC–9823 Rockville, MD 20852, 240–292–0189, reed.shabman@ nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Clinical Trial Planning and Implementation Grant (R34 and U01). Date: June 6, 2019. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Reed Solomon Shabman, Ph.D., Scientific Review Officer Scientific Review Program DEA/NIAID/NIH/DHHS, E:\FR\FM\17APN1.SGM 17APN1

Agencies

[Federal Register Volume 84, Number 74 (Wednesday, April 17, 2019)]
[Notices]
[Page 16025]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07709]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Committee on Vital and Health Statistics: Meeting

    Pursuant to the Federal Advisory Committee Act, the Department of 
Health and Human Services (HHS) announces the following advisory 
committee hearing.
    Name: National Committee on Vital and Health Statistics (NCVHS), 
Full Committee Meeting.
    Date and Times: Wednesday, June 5, 2019: 9:00 a.m.-5:00 p.m. (EST), 
Thursday, June 6, 2019: 8:30 a.m.-3:00 p.m. (EST)
    Place: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, 200 Independence Avenue SW, Rm. 505A, Washington, DC 
20201.
    Status: Open.
    Purpose: At the June 5-6, 2019 meeting, the Committee will 
deliberate draft recommendations for the HHS Secretary, move forward on 
activities outlined in the NCVHS 2019 workplan, and hold discussions on 
several health data policy topics. Anticipated action items during this 
meeting include a letter that outlines recommendations to the Secretary 
and an accompanying report focused on a framework for health 
information privacy and security.
    Specifically, the Privacy, Confidentiality and Security 
Subcommittee will provide an update to the full Committee regarding its 
working meeting held in March 2019 focused on health information 
privacy and security beyond the scope of HIPAA. This will include 
discussion of a draft report that will lay out a framework for 
extending basic protections for health information privacy and 
security, a result of two years of NCVHS hearings and deliberations, to 
understand the environment and consider what might be a workable 
framework that supports innovative use of health information to advance 
health and wellness and reduces administrative burden, while protecting 
the rights of information subjects. Together with this draft report, 
the Subcommittee plans to present a draft set of recommendations to the 
HHS Secretary based on the framework put forth in the report for full 
Committee deliberation.
    The Subcommittee on Standards will review the timeline of its ICD-
11 evaluation project and discuss any refinements that result from 
exploration of existing research on the impact of the transition to 
ICD-10, ICD-10-CM, and ICD-10-PCS. The Subcommittee will update the 
full Committee regarding progress on plans for an August expert 
roundtable meeting, which will focus on identifying research questions 
HHS could address to evaluate benefit and cost of the upcoming 
transition from ICD-10 to ICD-11 for mortality and morbidity. The 
Subcommittee will report on continued progress on the elements of a 
Predictability Roadmap in follow up to its December 2018 hearing--the 
current focus will be on evaluating the function and purpose of the 
Designated Standards Maintenance Organizations (DSMOs) in light of 
changes in the health care standards environment and the need for 
harmonization of administrative and clinical standards. Finally, the 
Subcommittee anticipates continuing discussion and possible activities 
in collaboration with the Office of the National Coordinator for Health 
Information and Technology (ONC) regarding the opportunity for burden 
reduction through convergence of administrative and clinical data 
standards using the prior authorization transaction as a use-case.
    The Subcommittee on Population Health will provide an update on its 
work to address community data needs, including use-cases, for the full 
Committee to consider providing as input to the Federal Data Strategy. 
The Committee will further refine the remainder of its 2019 workplan 
and discuss potential options moving into fiscal year 2020.
    The times and topics are subject to change. Please refer to the 
posted agenda for any updates.
    Contact Persons For More Information: Substantive program 
information may be obtained from Rebecca Hines, MHS, Executive 
Secretary, NCVHS, National Center for Health Statistics, Centers for 
Disease Control and Prevention, 3311 Toledo Road, Hyattsville, Maryland 
20782, telephone (301) 458-4715. Summaries of meetings and a roster of 
Committee members are available on the home page of the NCVHS website: 
www.ncvhs.hhs.gov, where further information including an agenda and 
instructions to access the broadcast of the meeting will also be 
posted.
    Should you require reasonable accommodation, please contact the CDC 
Office of Equal Employment Opportunity on (770) 488-3210 as soon as 
possible.

    Dated: April 11, 2019.
Sharon Arnold,
Associate Deputy Assistant Secretary for Planning and Evaluation, 
Science and Data Policy, Office of the Assistant Secretary for Planning 
and Evaluation.
[FR Doc. 2019-07709 Filed 4-16-19; 8:45 am]
 BILLING CODE 4151-05-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.